# Inhaled Fluticasone Effects on Upper Airway Patency in Obstructive Lung Disease

> **NCT01554488** · PHASE4 · TERMINATED · sponsor: **VA Office of Research and Development** · enrollment: 25 (actual)

## Conditions studied

- Asthma
- Chronic Obstructive Pulmonary Disease
- Obstructive Sleep Apnea

## Interventions

- **DRUG:** Inhaled Fluticasone Propionate

## Key facts

- **NCT ID:** NCT01554488
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-03-12
- **Primary completion:** 2016-02-03
- **Final completion:** 2016-04-07
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** Low subject accrual
- **Last updated:** 2020-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01554488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01554488, "Inhaled Fluticasone Effects on Upper Airway Patency in Obstructive Lung Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01554488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*